Suppr超能文献

用于玻璃体内给药的药瓶中的杂质。

Impurities in Drug Vials Intended for Intravitreal Medication.

作者信息

Pohl Lisa, Strudel Lisa, Dimopoulos Spyridon, Ziemssen Focke

机构信息

Center for Ophthalmology, Eberhard Karl University, Tuebingen, Germany.

出版信息

Case Rep Ophthalmol Med. 2020 Dec 2;2020:8824585. doi: 10.1155/2020/8824585. eCollection 2020.

Abstract

Sterility is an important prerequisite for minimizing the risk of severe vision loss due to endophthalmitis after intravitreal injections. We describe three cases series of incidents where an unclear contamination of the drug solution or syringe caused the injection process to stop and continue with a new preparation. During a period of 12 months with 30,502 intravitreal injections at a tertiary center, wherein 7,076 were of the drug Aflibercept drawn up from a glass vial, three cases of the critical incident reporting system relating to intravitreal injections were identified: (1) After a typical contact with the filter cannula, the glass of an Aflibercept vial was no longer intact. (2) In the course of another injection, there was a clear deposition of debris on the outer edge of the syringe when removing the attached filter cannula. (3) After inserting the syringe into the rubber top of the vial, a whitish particle of unclear origin was identified within the drug solution. Later, this contamination/particle was identified as part of the greyish rubber that was punched out with the cannula, according to the analyses of the material sent in and the manufacturer's investigations. Thus, even in busy clinics, visual inspection of the injection solution and materials used for impurities, preferably before and after pulling them out of a vial, must be an essential part of the injection process. Even when using ready-to-use prefilled syringes (PFS), vigilance must be kept high, knowing the risk of potential contamination.

摘要

无菌是将玻璃体内注射后因眼内炎导致严重视力丧失风险降至最低的重要前提条件。我们描述了三个系列的事件,药物溶液或注射器存在不明污染导致注射过程中断,随后更换新制剂继续注射。在一家三级中心进行的为期12个月的30,502次玻璃体内注射中,其中7,076次注射的是从玻璃小瓶中抽取的阿柏西普药物,共识别出三起与玻璃体内注射相关的严重事件:(1)在与滤器套管进行典型接触后,阿柏西普小瓶的玻璃不再完整。(2)在另一次注射过程中,取下连接的滤器套管时,注射器外缘有明显的碎屑沉积。(3)将注射器插入小瓶的橡胶顶部后,在药物溶液中发现了一个来源不明的白色颗粒。根据送检材料的分析和制造商的调查,后来确定这种污染/颗粒是随套管冲出的灰白色橡胶的一部分。因此,即使在繁忙的诊所,对注射溶液和用于注射的材料进行目视检查以查找杂质,最好在从小瓶中抽取前后进行检查,也必须是注射过程的重要组成部分。即使使用即用型预填充注射器(PFS),由于存在潜在污染风险,也必须保持高度警惕。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9f/8142807/42de9bc3fa6e/CRIOPM2020-8824585.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验